Clinical evaluation reveals improved kidney and nerve function with C-peptide and insulin in type 1 diabetes, indicating therapeutic potential for early complications.
These results indicate that combined treatment with C-peptide and insulin for 3 months may improve renal function by diminishing urinary albumin excretion and ameliorate autonomic and sensory nerve dysfunction in patients with Type 1 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: